Sequential Multicomponent Synthesis of 2‐(Imidazo[1,5‐α]pyridin‐1‐yl)‐1,3,4‐Oxadiazoles
Santosh Kurhade(University of Groningen), Alexander Dömlingꝉ(Institute of Molecular and Translational Medicine), Katarzyna Kurpiewska(Jagiellonian University), Fandi Sutanto(University of Groningen), Markella Konstantinidou(University of California, San Francisco), Justyna Kalinowska‐Tłuścik(Jagiellonian University)
Cited by 9
Related Papers
Covalent inhibitors: a rational approach to drug discovery
|RSC Medicinal Chemistry|2020|375
PROTACs– a game-changing technology
|Expert Opinion on Drug Discovery|2019|159
Molecular glues for protein-protein interactions: Progressing toward a new dream
|Cell chemical biology|2024|139
Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?
|Angewandte Chemie International Edition|2017|133
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)
|Expert Opinion on Therapeutic Patents|2016|104